Richmond Pharmacology

Richmond Pharmacology is a Clinical Research Organization (CRO) based in London, United Kingdom. It specializes in Early Phase Clinical Trials, Pharmacology, and Drug Development.

History

Richmond Pharmacology was established in 2001. Since its inception, it has conducted over 300 Early Phase Clinical Trials and has become one of the leading CROs in the UK.

Services

Richmond Pharmacology offers a range of services in the field of Clinical Research. These include:

• Early Phase Clinical Trials: Richmond Pharmacology conducts Phase I and Phase II clinical trials. These trials are crucial in determining the safety and efficacy of new drugs.

• Pharmacokinetics: This is the study of how a drug is absorbed, distributed, metabolized, and excreted by the body. Richmond Pharmacology has expertise in this area.

• Pharmacodynamics: This involves studying the biochemical and physiological effects of drugs on the body. Richmond Pharmacology conducts studies to understand these effects.

• Cardiac Safety Studies: Richmond Pharmacology conducts thorough QT/QTc studies as part of its cardiac safety services.

Facilities

Richmond Pharmacology operates from two clinical trial units located in London. These units are equipped with state-of-the-art facilities to conduct clinical trials.

Regulatory Compliance

Richmond Pharmacology complies with all relevant regulatory standards. It operates under the guidelines of the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA).

See Also

• Clinical Research Organization
• Early Phase Clinical Trials
• Pharmacokinetics
• Pharmacodynamics
• Cardiac Safety Studies

External Links

• Official website